In addition, a joint analysis of two GWAS on CAD patients identified an association with an intronic SNP in the SMAD3 gene [71] which was later shown to reduce enhancer activity and attenuate Smad3 expression [72,73]. Here, SMAD3 is linked to coronary artery disorder.